Quality of Life After Radiofrequency Ablation of Pancreatic Cancer

Not Applicable

Completed

• Conditions: Pancreatic Cancer
• Interventions: Procedure: Radiofrequency ablation

• Registration Number: NCT02637596
• Lead Sponsor: Brno University Hospital

Brief Summary

A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).

Detailed Description

Not available

Study Timeline

• Study Start: 2013-02
• Primary Completion: 2014-01
• Status Verified: 2015-12
• Study Completion: 2015-12
• Study First Submitted: 2015-12-18
• Study First Submitted QC: 2015-12-18
• Study First Posted: 2015-12-22
• Last Update Submitted: 2015-12-24
• Last Update Posted: 2015-12-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• histologically proved locally advanced or metastatic pancreatic cancer. Patients with histologically proved resectable pancreatic cancer with low Karnofsky index.

informed consent

Exclusion Criteria

• cystic tumor

age under 18

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
RFA group	Radiofrequency ablation	Twenty-fourth consecutive patients with histologically proved pancreatic cancer \[stage IIb (n=4), III (n=15), IV (n=5) \]underwent intraoperative RFA of primary tumor.

Primary Outcome Measures

Name	Time	Method
Quality of life after RFA of pancreatic cancer	3 years	Quality of life will be evaluated using EORTC C 30 and pan 26 questionaire preoperatively and three months after RFA

Secondary Outcome Measures

Name	Time	Method
3- months perioperative morbidity and mortality	3 years	Three months morbidity and mortality will be evaluated using Dindo-Clavien classification

Trial Locations

Locations (1)

Department of surgery Masaryk University Hostpital Brno; 🇨🇿 Brno, Bohunice, Czech Republic